Signal peptides (SPs) are short amino acid sequences in the amino terminus of many newly synthesized proteins that target proteins into, or across, membranes. Bioinformatic tools can predict SPs from amino acid sequences, but most cannot distinguish between various types of signal peptides. We present a deep neural network-based approach that improves SP prediction across all domains of life and distinguishes between three types of prokaryotic SPs.
Signal peptides (SPs) are found in many nascent polypeptides in virtually all organisms and target proteins to membrane-embedded export machines in Bacteria 1 , Archaea 2 and Eukarya 3 . SPs are found in secreted and transmembrane (TM) proteins, as well as in proteins inside organelles in eukaryotic cells. The general secretory pathway (Sec) directs protein translocation across the plasma membrane in prokaryotes and the endoplasmic reticulum membrane in eukaryotes. Bacteria, Archaea, chloroplasts and some mitochondria also have a Tat (twin-arginine translocation) pathway that recognizes generally longer and less hydrophobic SPs containing two consecutive arginines (R-R) in the amino-terminal region 4 . Unlike the Sec pathway, which transports proteins in an unfolded state, the Tat pathway can translocate folded proteins across the lipid membrane bilayer.
During or after membrane translocation, a signal peptidase removes the SP. Most SPs are removed by signal peptidase (SPase) I (LepB in Bacteria), which has orthologs in Archaea and Eukarya. In Eukarya, the SPase I ortholog is the only signal peptidase in the endoplasmic reticulum membrane. Bacterial lipoproteins are cleaved by a second signal peptidase, signal peptidase II (or Lsp), which cleaves SPs that contain a conserved carboxy-terminal 'lipobox' . This motif contains a cysteine immediately after the cleavage site (CS) 5 in both Bacteria and Archaea (although the actual SPase II has not been identified in Archaea 6 ) and is vital for membrane anchoring 7 . Bacterial type IV pilins are cleaved by a third signal peptidase, SPase III (prepilin peptidase or PilD in Bacteria, PibD in Archaea) 8 . Of note, Sec substrates can be processed by SPase I, SPase II or SPase III, but Tat substrates are only processed by SPase I or SPase II.
Many algorithms to predict SPs and their cleavage sites from amino acid (AA) sequences have been developed. SignalP was among the first publicly available methods 9 . Version 1 (ref. 9 ) was based on artificial neural networks, version 2 (ref. 10 ) introduced hidden Markov models, version 3 (ref.
11
) improved cleavage site predictions, and version 4 (ref. 12 ) improved discrimination of signal peptides and TM helices. SignalP versions 1 through 4 can only predict Sec-translocated SPs cleaved by SPase I. Specialized methods are available to predict Tat translocation or SPase II cleavage, some of which only apply to one type of SP and cannot differentiate between all three classes (Supplementary Table 1) .
Here, we present SignalP 5.0, a deep neural network-based method combined with conditional random field classification and optimized transfer learning for improved SP prediction. The deep recurrent neural network architecture is better suited to recognizing sequence motifs of varying length, such as SPs, than traditional feed-forward neural networks. The conditional random field imposes a defined grammar on the prediction and obviates the need for the post-processing step used in earlier versions of SignalP. Finally, the transfer learning makes it possible to obtain good performance on small divisions of the data set, notably the archaeal sequences (Online Methods).
SignalP 5.0 distinguishes three types of signal peptides in prokaryotes: Sec substrates cleaved by SPase I (Sec/SPI), Sec substrates cleaved by SPase II (Sec/SPII), and Tat substrates cleaved by SPase I (Tat/SPI). SignalP 5.0 cannot identify Tat substrates cleaved by SPase II, although these are known to exist 13 . We were unable to construct a sufficiently large data set of SPase III-cleaved proteins for training a machine learning method, therefore our algorithm cannot identify Sec substrates processed by SPase III.
We trained and tested SignalP 5.0 on Eukarya, Archaea, Grampositive bacteria and Gram-negative bacteria and on four types of proteins: Sec/SPI, Sec/SPII, Tat/SPI and 'Other' (globular proteins without SP and TM proteins with an experimentally verified TM segment within the first 70 AAs). Our training data comprised 20,758 proteins (Supplementary Table 2 ). We clustered the training set using CD-HIT 14 at 20% sequence identity. The data set was homology-partitioned into five sets. Each set had the same distribution of organisms and types of proteins. For each protein, the AAs were encoded using the normalized BLOSUM62 (ref. 15 ) matrix such that each position in the sequence became a vector of length 20 containing the AA substitution probabilities. The labels for each AA were: Sec/SPI signal, Tat/SPI signal, Sec/SPII signal, outer region, inner region, TM in-out, TM out-in, SPI CS and SPII CS (Online Methods).
We benchmarked SignalP 5.0 against 18 SP prediction algorithms that are available either as web-servers or standalone packages Table 1 ). One method, Signal-BLAST 16 , essentially carries out a BLAST 17 database look-up, rather than a prediction from scratch, and we found that most proteins in our benchmark data sets were correctly predicted because they were identical to a protein in Signal-BLAST's reference database. As this would make its performance artificially high, Signal-BLAST was excluded from our benchmark (Supplementary Note 1) .
Prediction performance of all SP detection algorithms was measured using the Matthews correlation coefficient (MCC) 18 , in which both true and false positive and negative predictions are counted at the sequence level. We used precision and recall to assess CS predictions, where precision is defined as the fraction of CS predictions that are correct, and recall is the fraction of real SPs that are predicted as the correct SP type and have the correct CS assigned. Table 5 ). 
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To demonstrate the reliability of SignalP 5.0, we studied the probability distribution of correct and incorrect predictions. Prediction confidence was assessed by examining the probabilities of the most likely class predicted by the model from the AA sequences (Supplementary Note 2 and Supplementary Fig. 1 ).
A common problem in CS prediction is that experimental data used to train prediction algorithms can have erroneous or uncertain annotations. To account for this uncertainty, we considered a window of one, two and three AAs around the annotated CS position, assuming that, if the annotation was incorrect, the correct position should be nearby. We reported a correct prediction if the predicted CS was within that window. The same was done for all other methods that were used in our benchmark (Supplementary Note 2 and Supplementary Fig. 2 ).
To construct an independent benchmark set for comparing SignalP 5.0 against all other prediction methods, we carried out a 20% homology reduction with CD-HIT between our training data set and the data set used for training the most recently published method, DeepSig 19 (which used the SignalP4 training data set). The result was a reduced benchmark data set of 8,811 proteins (derived from the 20,758 proteins of the training data set). Although the benchmark set is independent with regards to eukaryotic and bacterial Sec/SPI data, this is not the case for the Sec/SPII, Tat/SPI and archaeal data sets, for which many proteins were directly obtained from the training data sets of specialized predictors. In Supplementary Table 2, we report the constitution of the data sets for each organism type and category, both for training and for comparison.
Given that some methods were designed for a specific type of SP, and not all methods run on all organisms, we carried out three separate benchmarks (Sec/SPI, Sec/SPII and Tat/SPI SPs). Furthermore, because SignalP 5.0 is the only method capable of simultaneously predicting all types of SPs, each benchmark was run twice: first with only the respective SP type as the 'positive' data set and TM and globular proteins as the 'negative' data set and then adding the two remaining SP types to the 'negative' data set. Importantly, the performance of SignalP 5.0 was measured on a cross-validated mode, unlike the methods specialized for archaeal, Sec/SPII or Tat/SPI prediction, which contained some (or many) of the proteins of the benchmark already in their respective training data sets.
Benchmark results are summarized in Figs. 1-2 and Supplementary Tables 7-12. SignalP 5.0 has the best SP discrimination across all organisms in the Sec/SPI benchmark, with the exception of Gram-positive bacteria, for which it ranks second after SignalP 4.1 (Supplementary Table 7 and Fig. 1 ). It also has the highest CS recall in Eukarya and Bacteria, and the second highest 
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Nature BiotechNology CS recall in Archaea after PRED-SIGNAL 20 , which is a specialized method trained only on archaeal sequences. Finally, of all of the methods tested, SignalP 5.0 achieved the highest CS precision across all organisms (Supplementary Table 8 and Fig. 1 ).
The performance of the otherwise successful methods Philius 21 , Phobius 22 and SPOCTOPUS 23 on eukaryotic data was poorer than reported previously 12 . The reason for this discrepancy is that, in the current benchmark data set, the number of eukaryotic SPs is much lower than in the previous study 12 (210 here versus 3,462 in the previous study), which makes the eukaryotic part of the evaluation data set more imbalanced. Finally, the performance of TOPCONS2 (ref. 24 ), which is the only consensus method tested in our benchmark, is high in Bacteria, but not in Archaea or Eukarya, for which it ranks below average. For CS predictions, it is clear that a consensus method is not ideal, but we note that CS prediction was not in the intended scope of this tool (Supplementary Tables 7 and 8 and Fig. 1 ).
In the Sec/SPII SPs benchmark, SignalP 5.0 had superior performance across all metrics for all organisms, outperforming methods that were designed and optimized specifically for this particular type of SP (Supplementary Tables 9 and10 and Fig. 2) . In conclusion, SignalP 5.0 can predict proteome-wide SPs across all organisms, and classify them into Sec/SPI, Sec/SPII and Tat/SPI SPs, in many cases better than specialized predictors.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41587-019-0036-z.
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Sequence data. For eukaryotic and bacterial Sec/SPI signal peptides, we relied on the UniProt Knowledgebase release 2018_04 (ref. 27 ). Only reviewed entries (that is, from UniProtKB/SwissProt) were used, and hypothetical proteins were not included. We discarded protein sequences shorter than 30 AAs and we only considered signal peptides that had experimental evidence (ECO: 0000269) for the cleavage site. Gram-positive bacteria were defined as Firmicutes plus Actinobacteria. We did not include Tenericutes (Mycoplasma and related genera) since they do not seem to have a type I signal peptidase at all 28 . Gram-negative bacteria were defined as all other Bacteria. All sequences were shortened to the 70 N-terminal AAs. For archaeal Sec/SPI signal peptides, we added the (few) experimentally verified proteins from SwissProt to the ones from the PRED-SIGNAL method.
For Tat/SPI signal peptides, we relied on a combination of the training set of the PRED-TAT method (which had experimentally verified Tat proteins for Gram-negative and Gram-positive bacteria) together with the 'Tat signal profile' (PS51318) entry from the PROSITE database 29 . The status of PROSITE matches against SwissProt entries is manually assessed during the curation process. SwissProt curators evaluate the quality of the match according to the match score, the likelihood of the protein to contain such a domain and the appearance in other members of the protein family. The 'positive' status does not necessarily mean that the presence of the domain has been experimentally proven, but rather that the protein most probably contains such a domain according to the evaluation of the curators. For Archaea, we used proteins that were identified in the literature as being Tat/SPI (from the PRED-SIGNAL data sets) together with proteins belonging to the PS51318 entry of PROSITE.
A similar strategy was followed for the collection of the Sec/SPII data set, for which we used the respective PROSITE entry ('prokaryotic membrane lipoprotein lipid attachment site profile' , PS51257), together with experimentally verified lipoproteins, taken from the PRED-LIPO 30 data sets. It should be noted that there was no overlap between the lists from these two PROSITE entries (that is, we found no examples of proteins that belonged to the Tat/SPII group).
We must stress here that, as it can be seen from Supplementary Table 1 , the number of Sec/SPI signal peptides is relatively low compared to the Tat/SPI and Sec/SPII types. This is due to the fact that, for Tat/SPI and Sec/SPII signal peptides, we relied mainly on the PROSITE annotation and the PRED-TAT, PRED-SIGNAL and PRED-LIPO data sets, whereas for Sec/SPI signal peptides, we used the annotation from UniProt. In 2014, UniProt adopted a new evidence ontology. Before the change, an annotation was regarded as experimental if it lacked qualifiers such as 'Potential' , 'Probable' or 'By similarity'; after the change, only annotations with a specific literature reference are annotated as being experimental (evidence code ECO:0000269). If we compare the number of experimental Sec/ SPI SPs between the current version of SwissProt and the 2014_09 version (the last before adopting the new scheme), then we observe 1,371 eukaryotic, 280 Gramnegative and 118 Gram-positive Sec/SPI SPs that have lost their 'experimental' status (that is, are missing the ECO: 0000269 annotation). SignalP 5.0 identifies 1,338 out of 1,371 (97.59%) of the eukaryotic Sec/SPI SPs and, of them 1,089 with a correct CS position (79.43%). In Gram-negative bacteria, the corresponding numbers are 222 out of 280 (79.29%) for identification of Sec/SPI SPs and 195 out of 280 (69.64%) for correct CS prediction. Finally, in Gram-positive bacteria, 105 out of 118 (88.98%) of them were correctly identified, and 85 out of 118 (72.03%) were found to have the same CS as the annotated one. These results are quite close to the overall performance of SignalP 5.0, indicating that these proteins could be correct SPs; however, we could not trust their experimental status, which is why we did not include them.
For TM proteins, we relied on the TOPDB 31 database, which contains topological models of TM proteins based on either structural data (where there is interplay with the PDB_TM 32 database) or other experimental techniques, such as fusion with reporter enzymes, glycosylation studies, protease accessibility, immunolocalisation, etc. If a TM protein was found to also contain an SP, then this protein was classified under the SP data set.
Finally, we collected a globular proteins data set, again from UniProt 2018_04, i.e. proteins with a subcellular location annotated as cytosolic (cytosolic, nuclear, mitochondrial, plastid, and/or peroxisomal in Eukarya) and not belonging to the secretory pathway with experimental evidence (note that UniProt uses the term 'cytoplasm' for cytosol).
Methods for comparison.
In addition to the previous version of SignalP (SignalP 4.1), 17 other methods were selected for comparison of predictive performances (Supplementary Table 1 ). Most of the methods were downloaded and run locally on our computers or through their respective websites [33] [34] [35] [36] [37] . For the methods Signal-3L 2.0 (ref. 38 ), Signal-BLAST, Signal-CF 39 and SPEPlip
40
, we wrote Perl scripts to automate the process of submitting a sequence and collecting the results. Signal-BLAST was eventually excluded from the benchmark (Supplementary Note 1) .
SignalP 5.0 model architecture. SignalP 5.0 has three main novelties compared to previous versions: a powerful deep learning architecture 41 ; optimization using transfer learning 42 between multiple prediction tasks; and conditional random field classification 43, 44 . Fig. 3 ), is composed of three primary components: one-dimensional convolutions akin to learnable non-linear PSSMs, capturing short range correlations; bidirectional longshort term memory (LSTM) 45 cells capturing long range sequence dependencies; and a conditional random field for predicting the class labels.
Deep learning model. The deep learning model (Supplementary
Transfer and multimodal learning. Deep learning models require relatively large amounts of data in order to train the models without overfitting and, as described above, we collected a data set substantially larger than data sets previously used to successfully train deep learning models on protein sequences (for example, see refs.
46,]47 ). However, some of the categories still had limited amounts of data available (Supplementary Table 2 ). To improve performance in organism groups with little data (notably Archaea), SignalP 5.0 uses transfer learning between taxonomic groups as well as multimodal learning predicting several related tasks using the same model. We trained a single unified model for Archaea, Gram-positive bacteria, Gram-negative bacteria and Eukarya, which improves performance on the low-data task, as the model can learn generally useful features across all taxonomic groups. To inform the model about which taxonomic group a protein belongs to, we input an additional four-dimensional indicator vector into the LSTM cells of the model. To further improve performance, we employ multimodal learning, predicting both the individual AA labels as well as the global signal peptide type. Overall, transfer learning and multimodal learning means that, instead of having eight models, each specialized to one group and one task, we use a single model that works for all the groups and performs both predictions at once.
Conditional random field. The conditional random field models a joint distribution of the sequential labels y = y 1 … y T given the input sequence x = x 1 … x T using the following restricted form:
where h = h 1 … h T is the output of the core neural network model directly below the conditional random field, Z(h) is the normalization constant of the distribution p(y|x), ψ(h t ) is a linear model which takes h t as input and has the number of classes C outputs and φ t is a trainable transition matrix with C × C parameters:
Owing to the chain structure, inference can be carried out exactly using dynamic programming in O(TC 2 ) 48 . During training, where (x,y) is observed, we need to compute Z(h) for each training sequence as part of the likelihood p(y|x). During prediction, where only x is observed, we can calculate either the most probable sequence argmax y p(y|x) (using the Viterbi decoding algorithm) or the marginal probabilities p(y t |x), t = 1, ..., T. To make a single global prediction of whether a signal peptide is present or not in a protein, we take the average of the marginal probabilities across the sequence (nine classes: Sec/SPI signal, Tat/SPI signal, Sec/SPII signal, outer region, inner region, TM in-out, TM out-in, Sec SPI/Tat SPI cleavage site and Sec/SPII cleavage site) and perform an affine linear transformation into four classes (Sec/SPI, Sec/SPII, Tat/SPI, Other),
, so as to get the logit of a categorical distribution over the presence or not of a signal peptide. To predict the location of the cleavage site, we use Viterbi decoding, since this ensures that a predicted sequence of signal peptide positions is always followed by prediction of a cleavage site.
Neural network structure and optimization details. In this section, the neural network structure is described in more detail. The model is described sequentially going from the protein sequence input to predictions in which the output of a layer is used as input for the next:
1. 1D convolution with 32 filters and a kernel width of three. 2. Bidirectional LSTM with 64 hidden units in the forward and backward models. To include the taxonomic group information in the model, a 4D group indicator vector is concatenated to the input of the LSTM cells as illustrated in Supplementary Fig. 3 . 3. 1D convolution with 64 filters and kernel widths five. 4. 1D convolution with nine filters (matching the number of position-specific classes) and a kernel width of one. 5. Conditional random field for predictions. We calculate both the individual marginal probabilities of the labels at each position using the forward-backward algorithm and the global most likely label assignment for the entire sequence using Viterbi decoding. To predict the global label of the protein sequence, we average the marginal probabilities across the sequence producing a 9 × 1 vector. We linearly map that vector to a 4 × 1 vector followed by a softmax function producing the global label prediction. For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Sample size
The total number of protein sequences we used during the development and benchmarking of SignalP5 was 20,758. 
